Response to Platinum-Based Chemotherapy Predicts Survival in Lung Cancer Patients. Prospective Analysis of 340 Patients.

被引：0
|
作者：
Duarte, R. L. M.
Paschoal, M. E. M.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4440
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pharmacogenomics in lung cancer:: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy
    García-Campelo, R
    Alonso-Curbera, G
    Aparicio, LMA
    Rosell, R
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (12) : 2015 - 2026
  • [32] Prospective analysis of cancer stem cell drug response assay for glioblastoma patients.
    Ranjan, Tulika
    Howard, Candace M.
    Valluri, Jagan
    Yu, Alexander
    Aziz, Khaled
    Jho, David
    Julien, Terrence D.
    Leonardo, Jody
    Alberico, Anthony
    Cortese, Antonio
    Denning, Krista L.
    Claudio, Pier Paolo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair
    Yin, Ji-Ye
    Shen, Jie
    Dong, Zi-Zheng
    Huang, Qiong
    Zhong, Mei-Zuo
    Feng, De-Yun
    Zhou, Hong-Hao
    Zhang, Jian-Ting
    Liu, Zhao-Qian
    CLINICAL CANCER RESEARCH, 2011, 17 (13) : 4600 - 4609
  • [34] Molecular basis of eIF3a gene in therapeutic response of lung cancer patients to platinum-based chemotherapy
    Yin, Ji-ye
    Xu, Xiao-jing
    Zhou, Hong-hao
    Liu, Zhao-qian
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 18 - 18
  • [35] Circulating Survivin Protein Levels in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
    Puskas, Rita
    Bikov, Andras
    Horvath, Peter
    Lazar, Zsofia
    Kunos, Laszlo
    Nagy, Reka
    Pinter, Gabriella
    Galffy, Gabriella
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [36] Quality of life assessment of patients with metastatic lung cancer receiving platinum-based chemotherapy
    Kivrak-Bernardelli, Beril G.
    Macit, Caglar
    Kadioglu, S. Beril
    Salepci, Taflan
    Clark, Philip M.
    MARMARA PHARMACEUTICAL JOURNAL, 2013, 17 (02) : 120 - 130
  • [37] Platinum-based chemotherapy, glutathione metabolic pathway genes, and lung cancer survival
    Yang, P
    Williams, B
    Adjei, A
    Sun, Z
    Cunningham, J
    Pankratz, V
    Weinshilboum, R
    LUNG CANCER, 2005, 49 : S22 - S22
  • [38] A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma
    Saito, Motonobu
    Shiraishi, Kouya
    Matsumoto, Kenji
    Schetter, Aaron J.
    Ogata-Kawata, Hiroko
    Tsuchiya, Naoto
    Kunitoh, Hideo
    Nokihara, Hiroshi
    Watanabe, Shun-ichi
    Tsuta, Koji
    Kumamoto, Kensuke
    Takenoshita, Seiichi
    Yokota, Jun
    Harris, Curtis C.
    Kohno, Takashi
    CLINICAL CANCER RESEARCH, 2014, 20 (18) : 4784 - 4793
  • [39] Long term survival of patients with thyroid cancer: Analysis of 484 patients.
    Eichhorn, W
    Tabler, H
    Schreckenberger, M
    Lippold, R
    Eissner, D
    Bartenstein, P
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 322P - 322P
  • [40] Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy
    Woolston, Caroline M.
    Deen, Suha
    Al-Attar, Ahmad
    Shehata, Mohamed
    Chan, Stephen Y.
    Martin, Stewart G.
    FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 (08) : 1263 - 1272
12345